Black Radio Network

Your unfiltered news center. ®

The world you see depends upon the news you get. ®

HOME

ARTS

RSS

Today's Date: March 20, 2023

BONCHON DEBUTS TWO NEW KOREAN COMFORT FOOD FAVORITES • INT'L DAY OF HAPPINESS: Salesian Missions highlights programs that empower youth, giving them a sense of well-being and happines • Dirk Bontridder Appointed as CEO of New PerkinElmer Business Acquired by New Mountain Capital • Nationwide Ride of a Life Time Cycling Event on April 29 Aims to Raise $1.5 Million to Improve Children's Health • THURGOOD MARSHALL COLLEGE FUND AND HENNESSY SELECT 10 HBCU STUDENTS FOR 2023 COHORT OF HENNESSY FELLOWS • Innovative Climate Tech Company XNRGY Closes Growth Equity Financing to Expand Capacity • ALIGNMENT HEALTHCARE (ALHC) SHAREHOLDER ALERT - Andrews & Springer LLC Is Investigating Alignment Healthcare, Inc. For Poten • MERGER ALERT (CVT) - Andrews & Springer LLC Is Seeking More Cash for Shareholders of Cvent Holding Corp. • Aura Expands Kids Online Safety Capabilities with Safe Gaming Technology and Investment in Kidas • Cyclo Therapeutics Provides Business Update and Reports Full Year 2022 Financial Results • Liger's Top Woman Rallies for Atlanta Women and Girls Living in Poverty • Quantabio Adds Powerful Bead Booster Chemistry to Ultra-Fast sparQ RNA-Seq HMR Kit • KIDS TOO Sends Rallying Cry of Support for House Bill 3290: Urging Illinois Legislators to Protect Children from Predators in Sc • MERCURIA CREATES A NATURE-BASED INVESTMENT PLATFORM • Rubedo Life Sciences Presents In Vivo Efficacy Data Targeting Senescence Cells to Treat Dermatological Diseases • The Elmer's® Brand Launches New Activity to Inspire Kids' Imagination • AlmaLinux OS Foundation Welcomes OpenLogic and Hawk Host as Newest Sponsors • InvisiShield Technologies Collaborates with Gladstone Institutes to Accelerate Development of Intranasal Preventatives against S • Waters Introduces Next-Generation Alliance iS HPLC System Aimed at Reducing Up to 40% of Common Lab Errors • RayzeBio Completes Phase 1b Enrollment in ACTION-1 Study, Evaluating RYZ101 (Actinium-225 DOTATATE) in Neuroendocrine Tumors

We are pleased to inform you that the Minority News website is currently being redesigned. Please check back shortly, or subscribe using the link above to be notified of our relaunch. All of our 20,000 archived news articles are still available via the navigation bar above! Please feel free to browse through them. Thank you, and we will see you soon.